Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Mol Psychiatry
2017 Dec 01;2212:1776-1784. doi: 10.1038/mp.2016.125.
Show Gene links
Show Anatomy links
All naturally occurring autoantibodies against the NMDA receptor subunit NR1 have pathogenic potential irrespective of epitope and immunoglobulin class.
Castillo-Gómez E
,
Oliveira B
,
Tapken D
,
Bertrand S
,
Klein-Schmidt C
,
Pan H
,
Zafeiriou P
,
Steiner J
,
Jurek B
,
Trippe R
,
Prüss H
,
Zimmermann WH
,
Bertrand D
,
Ehrenreich H
,
Hollmann M
.
???displayArticle.abstract???
Autoantibodies of the IgG class against N-methyl-d-aspartate-receptor subunit NR1 (NMDAR1) were first described in anti-NMDAR encephalitis and seen as disease indicators. Recent work on together over 5000 individuals challenged this exclusive view by showing age-dependently up to >20% NMDAR1-autoantibody seroprevalence with comparable immunoglobulin class and titer distribution across health and disease. The key question therefore is to understand the properties of these autoantibodies, also in healthy carriers, in order to assess secondary complications and possible contributions to neuropsychiatric disease. Here, we believe we provide for human NMDAR1-autoantibodies the first comprehensive analysis of their target epitopes and functionality. We selected sera of representative carriers, healthy or diagnosed with very diverse conditions, that is, schizophrenia, age-related disorders like hypertension and diabetes, or anti-NMDAR encephalitis. We show that all positive sera investigated, regardless of source (ill or healthy donor) and immunoglobulin class, provoked NMDAR1 internalization in human-induced pluripotent stem cell-derived neurons and reduction of glutamate-evoked currents in NR1-1b/NR2A-expressing Xenopus oocytes. They displayed frequently polyclonal/polyspecific epitope recognition in the extracellular or intracellular NMDAR1 domains and some additionally in NR2A. We conclude that all circulating NMDAR1-autoantibodies have pathogenic potential regarding the whole spectrum of neuronal NMDAR-mediated effects upon access to the brain in situations of increased blood-brain-barrier permeability.
Begemann,
Modification of cognitive performance in schizophrenia by complexin 2 gene polymorphisms.
2010, Pubmed
Begemann,
Modification of cognitive performance in schizophrenia by complexin 2 gene polymorphisms.
2010,
Pubmed
Bhat,
Innate and adaptive autoimmunity directed to the central nervous system.
2009,
Pubmed
Busse,
Seroprevalence of N-methyl-D-aspartate glutamate receptor (NMDA-R) autoantibodies in aging subjects without neuropsychiatric disorders and in dementia patients.
2014,
Pubmed
Castillo-Gomez,
The brain as immunoprecipitator of serum autoantibodies against N-Methyl-D-aspartate receptor subunit NR1.
2016,
Pubmed
Coutinho,
Do neuronal autoantibodies cause psychosis? A neuroimmunological perspective.
2014,
Pubmed
Crisp,
Autoimmune synaptopathies.
2016,
Pubmed
Dahm,
Seroprevalence of autoantibodies against brain antigens in health and disease.
2014,
Pubmed
Dalmau,
Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies.
2008,
Pubmed
DeMarshall,
Utility of autoantibodies as biomarkers for diagnosis and staging of neurodegenerative diseases.
2015,
Pubmed
Diamond,
Brain-reactive antibodies and disease.
2013,
Pubmed
Diamond,
Losing your nerves? Maybe it's the antibodies.
2009,
Pubmed
Doss,
High prevalence of NMDA receptor IgA/IgM antibodies in different dementia types.
2014,
Pubmed
Gleichman,
Anti-NMDA receptor encephalitis antibody binding is dependent on amino acid identity of a small region within the GluN1 amino terminal domain.
2012,
Pubmed
Hammer,
Apolipoprotein E4 carrier status plus circulating anti-NMDAR1 autoantibodies: association with schizoaffective disorder.
2014,
Pubmed
Hammer,
Neuropsychiatric disease relevance of circulating anti-NMDA receptor autoantibodies depends on blood-brain barrier integrity.
2014,
Pubmed
Ho,
Site-directed mutagenesis by overlap extension using the polymerase chain reaction.
1989,
Pubmed
Hogg,
An automated system for intracellular and intranuclear injection.
2008,
Pubmed
,
Xenbase
Montagne,
Blood-brain barrier breakdown in the aging human hippocampus.
2015,
Pubmed
Moscato,
Acute mechanisms underlying antibody effects in anti-N-methyl-D-aspartate receptor encephalitis.
2014,
Pubmed
Ogawa,
Association of antibodies to the NR1 subunit of N-methyl-D-aspartate receptors with neuropsychiatric systemic lupus erythematosus.
2016,
Pubmed
Prüss,
Anti-NMDA Receptor Encephalitis in the Polar Bear (Ursus maritimus) Knut.
2015,
Pubmed
Schindelin,
Fiji: an open-source platform for biological-image analysis.
2012,
Pubmed
Shi,
Directed differentiation of human pluripotent stem cells to cerebral cortex neurons and neural networks.
2012,
Pubmed
Steiner,
Prevalence of N-methyl-D-aspartate receptor autoantibodies in the peripheral blood: healthy control samples revisited.
2014,
Pubmed
Steiner,
Increased prevalence of diverse N-methyl-D-aspartate glutamate receptor antibodies in patients with an initial diagnosis of schizophrenia: specific relevance of IgG NR1a antibodies for distinction from N-methyl-D-aspartate glutamate receptor encephalitis.
2013,
Pubmed
Streckfuss-Bömeke,
Comparative study of human-induced pluripotent stem cells derived from bone marrow cells, hair keratinocytes, and skin fibroblasts.
2013,
Pubmed
Sutton,
The immunopathogenesis of paraneoplastic neurological syndromes.
2002,
Pubmed
Toyka,
Myasthenia gravis: passive transfer from man to mouse.
1975,
Pubmed
Wandinger,
Anti-NMDA-receptor encephalitis: a severe, multistage, treatable disorder presenting with psychosis.
2011,
Pubmed
Wen,
B cell and/or autoantibody deficiency do not prevent neuropsychiatric disease in murine systemic lupus erythematosus.
2016,
Pubmed
Zandi,
Disease-relevant autoantibodies in first episode schizophrenia.
2011,
Pubmed
Zerche,
Preexisting Serum Autoantibodies Against the NMDAR Subunit NR1 Modulate Evolution of Lesion Size in Acute Ischemic Stroke.
2015,
Pubmed
Zhang,
Polyreactive autoantibodies in systemic lupus erythematosus have pathogenic potential.
2009,
Pubmed
Zheng,
NMDA-induced neuronal survival is mediated through nuclear factor I-A in mice.
2010,
Pubmed